Featured Research

from universities, journals, and other organizations

A new model of liver regeneration: Switch causes mature liver cells to revert back to stem cell-like state

Date:
June 5, 2014
Source:
Harvard University
Summary:
Scientists have new evidence in mice that it may be possible to repair a chronically diseased liver by forcing mature liver cells to revert back to a stem cell-like state. The researchers happened upon this discovery while investigating whether a biochemical cascade called Hippo, which controls how big the liver grows, also affects cell fate. The unexpected answer is that switching off the Hippo-signaling pathway in mature liver cells generates very high rates of dedifferentiation. This means the cells turn back the clock to become stem-cell like again, thus allowing them to give rise to functional progenitor cells that can regenerate a diseased liver.

When the Hippo pathway is inactivated, mature liver cells revert back to a stem cell-like state. Picture shows a group of cells transitioning from a mature cell type (green) to a stem cell type (red). White cells are the cells where Hippo is being inactivated.
Credit: Dean Yimlamai/Boston Children's Hospital

Harvard Stem Cell Institute scientists at Boston Children's Hospital have new evidence in mice that it may be possible to repair a chronically diseased liver by forcing mature liver cells to revert back to a stem cell-like state.

The researchers, led by Fernando Camargo, PhD, happened upon this discovery while investigating whether a biochemical cascade called Hippo, which controls how big the liver grows, also affects cell fate. The unexpected answer, published in the journal Cell, is that switching off the Hippo-signaling pathway in mature liver cells generates very high rates of dedifferentiation. This means the cells turn back the clock to become stem-cell like again, thus allowing them to give rise to functional progenitor cells that can regenerate a diseased liver.

The liver has been a model of regeneration for decades, and it's well known that mature liver cells can duplicate in response to injury. Even if three-quarters of a liver is surgically removed, duplication alone could return the organ to its normal functioning mass. This new research indicates that there is a second mode of regeneration that may be repairing less radical, but more constant liver damage, and chips away at a long-held theory that there's a pool of stem cells in the liver waiting to be activated.

"I think this study highlights the tremendous plasticity of mature liver cells," said Camargo, who is an associate professor in the Harvard Department of Stem Cell and Regenerative Biology, and based in the Stem Cell Program at Boston Children's Hospital. "It's not that you have a very small population of cells that can be recruited to an injury; almost 80 percent of hepatocytes [liver cells] can undergo this cell fate change."

Much of the work dissecting the biology of these changes and establishing that the dedifferentated cells are functional progenitors was carried out by the Cell paper's first co-authors Dean Yimlamai, MD, PhD, and Constantina Christodoulou, PhD, of Boston Children's Hospital.

The next step, Camargo said, would be to figure out how Hippo's activity changes in cells affected by chronic liver injury or diseases such as hepatitis. In the long term, this work could lead to drugs that manipulate the Hippo activity of mature liver cells inside of patients to spur dedifferentiation and hasten healing.

It might also be possible to control Hippo signaling to grow countless liver progenitor cells in a laboratory dish for transplant, which Camargo's team pursued in the Cell paper using mice born with a genetic liver disease. They cultured healthy liver progenitor cells and transplanted them into the diseased mice. Over a period of three or four months, the transplanted liver cells engrafted and the animals saw improvement of their condition.

"People have been trying to use liver cell transplants for metabolic diseases since the early 90s, but because of the source of cells -- discarded livers -- they were unsuccessful," Camargo said. "With this unlimited source of cells from a patient, we think that perhaps it's time to think again about doing hepatocyte or progenitor cell transplants in the context of liver genetic disorders."

The observation that mature liver cells dedifferentiate comes after a number of related studies published in the past year from Harvard researchers showing that mature cells in several different internal organs, including the kidneys, adrenal glands, and lungs, are more plastic than we once assumed.

"I think that maybe it is something that people have overlooked because the field has been so stem cell centric," said Camargo, also a Harvard Stem Cell Institute Principal Faculty member. "But I think the bottom line is that the cells that we have in our body are plastic, and understanding pathways that underlie that plasticity could be another way of potentially manipulating regeneration or expanding some kind of cell type for regenerative medicine."


Story Source:

The above story is based on materials provided by Harvard University. Note: Materials may be edited for content and length.


Journal Reference:

  1. Dean Yimlamai, Constantina Christodoulou, GiorgioG. Galli, Kilangsungla Yanger, Brian Pepe-Mooney, Basanta Gurung, Kriti Shrestha, Patrick Cahan, BenZ. Stanger, FernandoD. Camargo. Hippo Pathway Activity Influences Liver Cell Fate. Cell, 2014; 157 (6): 1324 DOI: 10.1016/j.cell.2014.03.060

Cite This Page:

Harvard University. "A new model of liver regeneration: Switch causes mature liver cells to revert back to stem cell-like state." ScienceDaily. ScienceDaily, 5 June 2014. <www.sciencedaily.com/releases/2014/06/140605141723.htm>.
Harvard University. (2014, June 5). A new model of liver regeneration: Switch causes mature liver cells to revert back to stem cell-like state. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/06/140605141723.htm
Harvard University. "A new model of liver regeneration: Switch causes mature liver cells to revert back to stem cell-like state." ScienceDaily. www.sciencedaily.com/releases/2014/06/140605141723.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins